Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 10/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 4/20 | 0.74 |
| ▸ | RAB9A | P51151 | 3/20 | 0.74 |
| ▸ | NPC1 | O15118 | 2/20 | 0.74 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.74 |
| ▸ | HPGD | P15428 | 2/20 | 0.74 |
| ▸ | ATM | Q13315 | 1/20 | 0.74 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.74 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.74 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | RHOA | P61586 | 1/20 | 0.57 |
| ▸ | GLA | P06280 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11030583 | 0.87 | HTT (0.77) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL30534581 | 0.85 | HTT (0.74) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL10991784 | 0.85 | HTT (0.74) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL10904809 | 0.85 | HTT (0.74) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL28766737 | 0.84 | HTT (0.71) | HTTALDH1A1KMT2AMEN1RAB9A | |
| Formaldehyde SCHEMBL28251520 | 0.82 | HTT (0.69) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL10995842 | 0.81 | HTT (0.68) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL27259671 | 0.81 | MEN1 (0.73) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL3916025 | 0.80 | HTT (0.72) | HTTALDH1A1KMT2AMEN1RAB9A | |
| SCHEMBL9815623 | 0.79 | HTT (0.66) | HTTALDH1A1KMT2AMEN1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104817539-B | 2 phenoxyquinoxaline derivatives and its medical usage | 三峡大学 | 2017-06-09 | — | — | CN | claimed |
| CN-104817539-A | 2-phenoxy quinoxaline derivative and pharmaceutical use thereof | UNIV CHINA THREE GORGES CTGU | 2015-08-05 | — | — | CN | claimed |
| CN-119899153-A | Production method of quizalofop-p-ethyl | 河北农必威生物科技有限公司 | 2025-04-29 | — | — | CN | disclosed |
| CN-104817539-B | 2 phenoxyquinoxaline derivatives and its medical usage | 三峡大学 | 2017-06-09 | — | — | CN | disclosed |
| CN-104817539-B | 2 phenoxyquinoxaline derivatives and its medical usage | 三峡大学 | 2017-06-09 | — | — | CN | disclosed |
| CN-104817539-B | 2 phenoxyquinoxaline derivatives and its medical usage | 三峡大学 | 2017-06-09 | — | — | CN | disclosed |
| CN-104817539-A | 2-phenoxy quinoxaline derivative and pharmaceutical use thereof | UNIV CHINA THREE GORGES CTGU | 2015-08-05 | — | — | CN | disclosed |
| CN-104817539-A | 2-phenoxy quinoxaline derivative and pharmaceutical use thereof | UNIV CHINA THREE GORGES CTGU | 2015-08-05 | — | — | CN | disclosed |
| CN-104817539-A | 2-phenoxy quinoxaline derivative and pharmaceutical use thereof | UNIV CHINA THREE GORGES CTGU | 2015-08-05 | — | — | CN | disclosed |
| US-9060517-B2 | Nitrogenated heterocyclic compound and agricultural or horticultural fungicide | NIPPON SODA CO., LTD. (JP) | 2015-06-23 | — | — | US | disclosed |
| US-20140073792-A1 | NITROGENATED HETEROCYCLIC COMPOUND AND AGRICULTURAL OR HORTICULTURAL FUNGICIDE | NIPPON SODA CO., LTD. (JP) | 2014-03-13 | — | — | US | disclosed |
| US-8071710-B2 | Thermoplastic polyphenoxyquinoxaline and method of preparing the same | THE UNIVERSITY OF AKRON (US) | 2011-12-06 | — | — | US | disclosed |
| US-5696119-A | SOLID TUMORS, LEUKEMIA | THE DUPONT MERCK PHARMACEUTICAL COMPANY (US) | 1997-12-09 | — | — | US | disclosed |
| WO-1994013647-A1 | (2-QUINOXALINYLOXY)PHENOXYPROPANOIC ACIDS AND RELATED DERIVATIVES AS ANTICANCER AGENTS | THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) | 1994-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140073792-A1 | NITROGENATED HETEROCYCLIC COMPOUND AND AGRICULTURAL OR HORTICULTURAL FUNGICIDE | CBR3, CBR1, NOX3 | HTT 1373/4885ALDH1A1 1986/4885KMT2A 1871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.